TREM2 signaling, miRNA-34a and the extinction of phagocytosis

Frontiers in Cellular Neuroscience

Volumn , Issue AUG, 2013, Pages

  Zhao, Yuhai ^a   Lukiw, Walter J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Anti miRNA; Inflammation; Micro RNA; miRNA 34a; NF ; Phagocytosis; TREM2

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 34A; TRANSCRIPTION FACTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; DOWN REGULATION; GENETIC ASSOCIATION; HIPPOCAMPAL CA1 REGION; HUMAN; INNATE IMMUNITY; MICROGLIA; MOUSE; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; TRANSGENIC MOUSE; UPREGULATION;

EID: 84885077268     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00131     Document Type: Article

References (17)

1. Agostini, M., Tucci, P., Killick, R., Candi, E., Sayan, B. S., Rivetti di Val Cervo, P., et al. (2011). Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc. Natl. Acad. Sci. U.S.A. 108, 21093-21098. doi: 10.1073/pnas.1112061109
2. Boon, R. A., Lekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., et al. (2013). MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110. doi: 10.1038/nature11919
3. Bouchie, A. (2013). First microRNA mimic enters clinic. Nat. Biotechnol. 31, 577. doi: 10.1038/nbt0713-577
4. Forabosco, P., Ramasamy, A., Trabzuni, D., Walker, R., Smith, C., Bras, J., et al. (2013). Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol. Aging. doi: 10.1016/j.neurobiolaging.2013.05.001. [Epub ahead of print].
5. Golde, T. E., Streit, W. J., and Chakrabarty, P. (2013). Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease. Alzheimers Res. Ther. 5, 24-27. doi: 10.1186/alzrt178
6. Gonzalez Murcia, J. D., Schmutz, C., Munger, C., Perkes, A., Gustin, A., Peterson, M., et al. (2013). Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the cache county study. Neurobiol. Aging. doi: 10.1016/j.neurobiolaging.2013.06.004. [Epub ahead of print].
7. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., et al. (2013). Alzheimer genetic analysis group. TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368, 117-127. doi: 10.1056/NEJMe1213157
8. Hampel, H., and Lista, S. (2013). Have we learnt all we need to know from genetic studies-is genetics over in Alzheimer's disease. Alzheimers Res. Ther. 5, 11. doi: 10.1186/alzrt165
9. Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., et al. (2013). Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116. doi: 10.1056/NEJMoa1211103
10. Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., et al. (2009). MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132, 3342-3352. doi: 10.1093/brain/ awp300
11. Kaltschmidt, B., and Kaltschmidt, C. (2009). NFkappaB in the Nervous System. Cold Spring Harb. Perspect. Biol. 1:a001271. doi: 10.1101/cshperspect.a001271
12. Lattante, S., Le Ber, I., Camuzat, A., Dayan, S., Godard, C., Van Bortel, I., et al. (2013). TREM2 mutations are rare in a French cohort of patients with frontotemporal dementia. Neurobiol. Aging 34, 2443. e1-2443. e2. doi: 10.1016/j.neurobiolaging.2013.04.030
13. Lukiw, W. J. (2013). Antagonism of NF-κB-upregulated micro RNAs (miRNAs) in sporadic Alzheimer's disease (AD): anti-NF-κB vs. antimiRNA strategies. Front. Genet. 4, 77-79. doi: 10.3389/fgene.2013.00077
14. Neumann, H., and Daly, M. J. (2013). Variant TREM2 as risk factor for Alzheimer's disease. N. Engl. J. Med. 368, 182-184. doi: 10.1056/NEJMe1213157
15. Schipper, H. M., Maes, O. C., Chertkow, H. M., and Wang, E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene. Regul. Syst. Bio. 1, 263-274.
16. Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., et al. (2009). miRNA-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 80, 268-273. doi: 10.1016/j.brainresbull.2009.08.006
17. Zhao, Y., Bhattacharjee, S., Jones, B. M., Dua, P., Alexandrov, P. N., Hill, J. M., et al. (2013). Regulation of TREM2 expression by an NF-κBsensitive miRNA-34a. Neuroreport 24, 318-323. doi: 10.1097/WNR.0b013e32835fb6b0